Newsfiscal.ai
Enlivex Announces Cost Reduction Plan to Focus on Phase 2b Clinical Trial
· Published
Article summary
Enlivex Ltd. has initiated a cost reduction plan to lower cash burn and prioritize resources for its Phase 2b clinical trial of Allocetra™ for knee osteoarthritis.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…